Log In
BCIQ
Print this Print this
 

DT-200 (formerly GLPG0492)

Also known as: SARM compound

  Manage Alerts
Collapse Summary General Information
Company Galapagos N.V.
DescriptionSelective androgen receptor modulator (SARM)
Molecular Target Androgen receptor
Mechanism of ActionSelective androgen receptor modulator (SARM)
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationMuscular dystrophy
Indication DetailsTreat Duchenne muscular dystrophy (DMD)
Regulatory Designation
PartnerAkashi Therapeutics Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

03/25/2013

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today